
September 1999
AVOIDING MEDICATION ERRORS:
USING APPROVED MEDICAL ABBREVIATIONS
Using inappropriate medical abbreviations for drug names during the prescribing process has been identified as one of the factors that may increase the risk of causing a serious medication error. The following scenario demonstrates a mis-abbreviation drug example that has occurred at Kansas University Medical Center but fortunately, was recognized and did not result in the patient receiving the wrong medication.
A patient was admitted to general care nursing unit with the following medications prescribed upon admission,Atarax 50 mg PO q 6-8 hr prn
Benadryl 25 g PO q 6hr
TAC 0.1% ointment to skin BID
Tylenol 650 mg q 4 hr prn
Mylanta 30 cc PO q 6 hr prn
The TAC order was interpreted as tetracaine-adrenalin-cocaine, but there was confusion as the pharmacy only stocked TAC gel not an ointment and the dosage regimen indicated for this product appeared inapproriate. When the prescriber was notified, it was determined that the drug intended for administration was triamcinolone.
A list of approved abbreviations at KUMC can be found in the front of the printed formulary. Regulations for the use of abbreviations at Kansas University Medical Center have been approved by the Executive Committee of the Medical Staff include the following:
The Pharmacy and Therapeutics Committee will be working in conjunction with Medical Records to update the approved medical abbreviations listing in regards to drug name abbreviations.